TC
BLUE

TFS Capital’s bluebird bio BLUE Stock Holding History

TFS Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,725
Closed -$802K – 990
2014
Q3 		$802K Buy
+1,725
New +$796K 0.07% 446
2014
Q2 		– Sell
-1,024
Closed -$302K – 1134
2014
Q1 		$302K Buy
+1,024
New +$310K 0.02% 1010

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TFS Capital's BLUE Position: Q4 2014 in Review

TFS Capital sold out of bluebird bio (BLUE) in Q4 2014, closing a stake of 1,725 shares — an estimated $802K sold.

TFS Capital first reported a position in BLUE in Q1 2014 and held it in 2 quarters. The position peaked at $802K in Q3 2014. 169 funds tracked by Wall St. Rank hold BLUE as of Q4 2014.

  • TFS Capital reported no remaining bluebird bio position as of Q4 2014 after selling out during the quarter.
  • TFS Capital sold 1,725 bluebird bio shares in Q4 2014, an estimated $802K.
  • TFS Capital first reported a position in bluebird bio in Q1 2014 and held it in 2 quarters.
  • TFS Capital's bluebird bio position peaked at $802K in Q3 2014.
  • 169 funds tracked by Wall St. Rank held bluebird bio as of Q4 2014.

Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.